 Connection
Raymond Estacio to Antihypertensive Agents
This is a "connection" page, showing publications Raymond Estacio has written about Antihypertensive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.560 |
|
|
|
-
Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):451-7.
Score: 0.257
-
Pflederer MC, Estacio RO, Krantz MJ. Is 60 the New 80 in Hypertension? J Gen Intern Med. 2016 08; 31(8):958-60.
Score: 0.102
-
Chonchol M, Dale R, Schrier RW, Estacio R. Serum phosphorus and cardiovascular mortality in type 2 diabetes. Am J Med. 2009 Apr; 122(4):380-6.
Score: 0.063
-
Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol. 2007 Aug; 3(8):428-38.
Score: 0.056
-
Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Am Heart J. 2003 Jun; 145(6):993-8.
Score: 0.042
-
Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003 Feb 11; 107(5):753-6.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|